Exosomal Vimentin from Adipocyte Progenitors Protects Fibroblasts against Osmotic Stress and Inhibits Apoptosis to Enhance Wound Healing.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
28 Apr 2021
Historique:
received: 01 04 2021
revised: 20 04 2021
accepted: 20 04 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 9 6 2021
Statut: epublish

Résumé

Mechanical stress following injury regulates the quality and speed of wound healing. Improper mechanotransduction can lead to impaired wound healing and scar formation. Vimentin intermediate filaments control fibroblasts' response to mechanical stress and lack of vimentin makes cells significantly vulnerable to environmental stress. We previously reported the involvement of exosomal vimentin in mediating wound healing. Here we performed in vitro and in vivo experiments to explore the effect of wide-type and vimentin knockout exosomes in accelerating wound healing under osmotic stress condition. Our results showed that osmotic stress increases the size and enhances the release of exosomes. Furthermore, our findings revealed that exosomal vimentin enhances wound healing by protecting fibroblasts against osmotic stress and inhibiting stress-induced apoptosis. These data suggest that exosomes could be considered either as a stress modifier to restore the osmotic balance or as a conveyer of stress to induce osmotic stress-driven conditions.

Identifiants

pubmed: 33925176
pii: ijms22094678
doi: 10.3390/ijms22094678
pmc: PMC8125065
pii:
doi:

Substances chimiques

Vimentin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Natural Science Foundation of China
ID : National Natural Science Foundation of China
Organisme : Science, Technology & Innovation Commission of Shenzhen Municipality
ID : JCY20170818164756460, JCYJ20180307154700308, JCYJ20170818163844015
Organisme : Sigrid Juselius Stiftelse
ID : 2018-2021
Organisme : Åbo Akademi University
ID : 2018-2021

Références

Biomol Concepts. 2012 Aug;3(4):345-364
pubmed: 22977648
Cell Physiol Biochem. 2011;28(6):1231-46
pubmed: 22179011
Sci Rep. 2016 Oct 18;6:35376
pubmed: 27752092
Nature. 2008 May 15;453(7193):314-21
pubmed: 18480812
J Cell Physiol. 2002 Aug;192(2):234-43
pubmed: 12115730
Adv Wound Care (New Rochelle). 2018 Feb 1;7(2):47-56
pubmed: 29392093
Adv Drug Deliv Rev. 2018 Apr;129:394-406
pubmed: 29408181
PLoS One. 2011 Feb 25;6(2):e16899
pubmed: 21364924
Theranostics. 2019 Jan 30;9(4):1015-1028
pubmed: 30867813
Biomed Res Int. 2016;2016:2428915
pubmed: 28078284
J Cell Sci. 2002 Nov 15;115(Pt 22):4341-51
pubmed: 12376565
Cell Death Discov. 2019 Mar 19;5:79
pubmed: 30911413
J Surg Res. 2016 Dec;206(2):418-426
pubmed: 27884338
Bioengineering (Basel). 2018 Dec 30;6(1):
pubmed: 30598033
Traffic. 2008 Feb;9(2):230-50
pubmed: 17999726
J Extracell Vesicles. 2013 Mar 05;2:
pubmed: 24009895
Biol Res Nurs. 2015 Mar;17(2):135-41
pubmed: 25681269
J Gen Physiol. 2015 May;145(5):373-80
pubmed: 25870207
J Extracell Vesicles. 2012 Apr 16;1:
pubmed: 24009886
J Invest Dermatol. 2000 Oct;115(4):714-8
pubmed: 10998149
PLoS One. 2013 Jul 11;8(7):e68301
pubmed: 23874579
J Biol Chem. 2009 Dec 4;284(49):34211-22
pubmed: 19801663
Oncotarget. 2016 Oct 11;7(41):67387-67402
pubmed: 27602764
Front Neurosci. 2017 Jan 31;11:26
pubmed: 28197068
Mol Biol Cell. 2018 Jul 1;29(13):1555-1570
pubmed: 29718762
BMC Endocr Disord. 2017 Oct 10;17(1):63
pubmed: 29017477
Cytoskeleton (Hoboken). 2020 Oct;77(10):399-413
pubmed: 32978896
Biomed Res Int. 2016;2016:3943481
pubmed: 27413744
Cell Mol Life Sci. 2018 Jan;75(2):193-208
pubmed: 28733901
Crit Care. 2015 Jun 12;19:243
pubmed: 26067660
Am J Physiol Cell Physiol. 2008 Apr;294(4):C1046-55
pubmed: 18272822
Trends Cell Biol. 2015 Jul;25(7):398-407
pubmed: 25813429
Nat Commun. 2015 May 13;6:7164
pubmed: 25968605
Arch Surg. 1967 Feb;94(2):218-22
pubmed: 6016270
Semin Cancer Biol. 2014 Oct;28:3-13
pubmed: 24769058
Proteomics. 2009 Oct;9(19):4457-67
pubmed: 19670369
Glia. 2019 Apr;67(4):703-717
pubmed: 30485542
J Cell Biochem. 2019 Aug;120(8):13168-13176
pubmed: 30887571
BMC Cancer. 2012 Sep 24;12:421
pubmed: 22998595
Am J Transplant. 2018 Jul;18(7):1626-1635
pubmed: 29316217
Biomaterials. 2020 Oct;257:120264
pubmed: 32791387
Biochim Biophys Acta. 2013 Mar;1833(3):712-22
pubmed: 23178740
Oncotarget. 2016 Aug 23;7(34):54852-54866
pubmed: 27363026
Am J Case Rep. 2018 May 15;19:562-566
pubmed: 29760374
J Cell Sci. 2000 Jul;113 ( Pt 13):2455-62
pubmed: 10852824

Auteurs

Sepideh Parvanian (S)

School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China.
Faculty of Science and Engineering, Åbo Akademi University & Turku Bioscience Centre, 20520 Turku, Finland.

Hualian Zha (H)

School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China.

Dandan Su (D)

School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China.

Lifang Xi (L)

School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China.

Yaming Jiu (Y)

Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai 200031, China.
Institute Pasteur of Shanghai and Institute of Pathogen Biology, University of Chinese Academy of Sciences, 52 Sanlihe Rd., Xicheng District, Beijing 100019, China.

Hongbo Chen (H)

School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China.

John E Eriksson (JE)

Faculty of Science and Engineering, Åbo Akademi University & Turku Bioscience Centre, 20520 Turku, Finland.

Fang Cheng (F)

School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China.
Faculty of Science and Engineering, Åbo Akademi University & Turku Bioscience Centre, 20520 Turku, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH